NOVT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Novanta Inc (NOVT) is not a strong buy for a beginner, long-term investor at this moment. While the company shows some positive financial growth and hedge fund interest, the technical indicators are neutral to bearish, and the stock's recent underperformance compared to the S&P 500 suggests limited immediate upside potential. Additionally, there are no strong proprietary trading signals or significant catalysts to justify an entry at the current price.
The MACD is negative and expanding (-0.98), indicating bearish momentum. The RSI is neutral at 43.029, and moving averages are converging, showing no clear trend. The stock is trading below its pivot level of 139.524, with support at 131.903 and resistance at 147.145. Overall, the technical indicators suggest a neutral to slightly bearish trend.
Hedge funds are significantly increasing their positions in the stock, with a 140% increase in buying over the last quarter. The company reported an 8.52% YoY revenue increase in Q4 2025, and the CEO announced plans to improve margins and cash flow.
The stock has underperformed the S&P 500 over the past year, remaining flat while the index gained 16%. Net income decreased YoY in 2025, and gross margin dropped by 4.71%. Technical indicators are neutral to bearish, and there are no strong proprietary trading signals.
In Q4 2025, revenue increased by 8.52% YoY to $258.35 million, and net income rose by 6.12% YoY to $17.47 million. However, EPS dropped by 2.17% YoY to 0.45, and gross margin declined to 40.7%, down 4.71% YoY. The financial performance shows mixed results, with revenue and income growth but declining profitability metrics.
Baird analyst Robert Mason raised the price target to $150 from $138, maintaining a Neutral rating. Analysts see potential for accelerating sales and margins, but the Neutral rating reflects limited immediate upside.
